Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

This study has been completed.
Sponsor:
Information provided by:
Canadian Cancer Trials Group
ClinicalTrials.gov Identifier:
NCT00006036
First received: July 5, 2000
Last updated: November 7, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: No date given
Publications: